Inhibition of tumor angiogenesis during cisplatin chemotherapy for bladder cancer improves treatment outcome-Reference-Cited by-同舟云学术

Inhibition of tumor angiogenesis during cisplatin chemotherapy for bladder cancer improves treatment outcome

Published:2005-02 Issue:2 Volume:65 Page:395-399
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Kong Chuize,Zhu Yuyan,Sun Changcheng,Li Zeliang,Sun Zhixi,Zhang Xianghua,Takanaka Ikusama

Publisher

Elsevier BV

Subject

Urology

Reference18 articles.

1. Angiogenesis in bladder cancer;Bochner;J Natl Cancer Inst,1995

2. Relationship of tumor angiogenesis and nuclear p53 accumulation in invasive bladder cancer;Bochner;Clin Cancer Res,1997

3. The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy;Inoue;Clin Cancer Res,2000

4. Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in phase I/II trial with paclitaxel, cisplatin and gemcitabine;Bellmunt;Cancer,2002

5. Angiogenesis in bladder cancer—prognostic marker and target for future therapy;Streeter;Surg Oncol,2002

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer combination therapies by angiogenesis inhibitors; a comprehensive review;Cell Communication and Signaling;2022-04-07

2. Identification of Immune-Related Subtypes and Characterization of Tumor Microenvironment Infiltration in Bladder Cancer;Frontiers in Cell and Developmental Biology;2021-08-31

3. The Effects on Angiogenesis of Relevant Inorganic Chemotherapeutics;Current Topics in Medicinal Chemistry;2021-01-11

4. Potential therapeutic strategies for non - muscle invasive bladder cancer based on association of intravesical immunotherapy with P-MAPA and systemic administration of cisplatin and doxorubicin;International braz j urol;2016-10

5. Erlotinib-Cisplatin Combination Inhibits Growth and Angiogenesis through c-MYC and HIF-1α in EGFR-Mutated Lung Cancer In Vitro and In Vivo;Neoplasia;2015-02